Bold Brain Ventures is a leading investor in early-stage life sciences companies, focusing on AI-enabled technologies in healthcare, particularly in radiology. The firm specializes in Series B investments, demonstrating a commitment to supporting companies as they scale and expand their operations.

Elucid Bioimaging, with $27 million in total funding, is a notable portfolio company. Bold Brain offers unique value-add services through its Venture Capital Network for Doctors™, providing opportunities for healthcare professionals to invest alongside their team, access board seats, and engage in paid consulting roles at portfolio companies. The firm also maintains the Bold Brain Blog, sharing insights on AI in healthcare.